Literature DB >> 11789777

Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.

R K Li1, D A Mickle, R D Weisel, V Rao, Z Q Jia.   

Abstract

BACKGROUND: This study was designed to determine the optimal time for cell transplantation after myocardial injury.
METHODS: The left ventricular free wall of adult rat hearts was cryoinjured and the animals were sacrificed at 0, 1, 2, 4, and 8 weeks for histologic studies. Fetal rat cardiomyocytes (transplant) or culture medium (control) were transplanted immediately (n = 8), 2 weeks (n = 8), and 4 weeks (n = 12) after cryoinjury. At 8 weeks, rat heart function, planimetry, and histologic studies were performed.
RESULTS: Cryoinjury produced a transmural injury. The inflammatory reaction was greatest during the first week but subsided during the second week after cryoinjury. Scar size expanded (p < 0.01) at 4 and 8 weeks. Cardiomyocytes transplanted immediately after cryoinjury were not found 8 weeks after cryoinjury. Scar size and myocardial function were similar to the control hearts. Cardiomyocytes transplanted at 2 and 4 weeks formed cardiac tissue within the scar, limited (p < 0.01) scar expansion, and had better (p < 0.001) heart function than the control groups. Developed pressure was greater (p < 0.01) in the hearts with transplanted cells at 2 weeks than at 4 weeks.
CONCLUSIONS: Cardiomyocyte transplantation was most successful after the inflammatory reaction resolved but before scar expansion.

Entities:  

Mesh:

Year:  2001        PMID: 11789777     DOI: 10.1016/s0003-4975(01)03216-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  27 in total

Review 1.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

2.  Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

Authors:  Na Li; Yue-Jin Yang; Hai-Yan Qian; Qing Li; Qian Zhang; Xiang-Dong Li; Qiu-Ting Dong; Hui Xu; Lei Song; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

3.  Timed Delivery of Therapy Enhances Functional Muscle Regeneration.

Authors:  Christine A Cezar; Praveen Arany; Sarah A Vermillion; Bo Ri Seo; Herman H Vandenburgh; David J Mooney
Journal:  Adv Healthc Mater       Date:  2017-07-13       Impact factor: 9.933

Review 4.  Biomaterial-based delivery for skeletal muscle repair.

Authors:  Christine A Cezar; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2014-09-28       Impact factor: 15.470

Review 5.  Stem cell therapy for chronic myocardial infarction.

Authors:  Manuel Mazo; Beatriz Pelacho; Felipe Prósper
Journal:  J Cardiovasc Transl Res       Date:  2010-01-21       Impact factor: 4.132

6.  Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats.

Authors:  Junming Tang; Jianing Wang; Fei Zheng; Xia Kong; Linyun Guo; Jianye Yang; Lei Zhang; Yongzhang Huang
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

7.  Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction.

Authors:  Chen-yang Jiang; Chun Gui; Ai-na He; Xin-yang Hu; Jie Chen; Yun Jiang; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2008-08       Impact factor: 3.066

8.  Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction.

Authors:  Rutger-Jan Swijnenburg; Johannes A Govaert; Koen E A van der Bogt; Jeremy I Pearl; Mei Huang; William Stein; Grant Hoyt; Hannes Vogel; Christopher H Contag; Robert C Robbins; Joseph C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2009-11-17       Impact factor: 7.792

Review 9.  Myoblast-based cell transplantation.

Authors:  Philippe Menasché
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

10.  Therapeutic potential of human adipose stem cells in a rat myocardial infarction model.

Authors:  Seal Hwangbo; Jongok Kim; Sungho Her; Hyekyung Cho; Jongho Lee
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.